https://nl.marketscreener.com/koers/aandeel/BEYONDSPRING-INC-34241928/nieuws/BeyondSpring-Inc-Eerste-patient-ingeschreven-in-Fase-2-studie-met-Plinabuline-Keytruda-en-Docetax-43148165/?utm_source=telegram&utm_medium=social&utm_campaign=share